Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
AMERICAN SALES COMPANY, INC. v. SMITHKLINE BEECHAM CORPORATION
Case Number:
2:08-cv-03149
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
-
June 14, 2013
Judge Approves $150M Flonase Antitrust Accord
A Pennsylvania federal judge on Friday approved a $150 million settlement, including $50 million in attorneys' fees, ending a direct purchaser antitrust class action accusing GlaxoSmithKline of filing sham petitions with federal authorities to delay generic alternatives to Flonase nasal spray.
-
November 01, 2012
Ex-FDA Head To Testify In GSK Flonase Antitrust Row
A Pennsylvania federal judge struck a blow to GlaxoSmithKline PLC on Thursday, ruling that plaintiffs in a class action accusing it of illegally blocking development of a generic Flonase could tap former U.S. Food and Drug Administration chief David Kessler as an expert witness.
-
June 02, 2011
GSK Denied Quick Win In Flonase Antitrust Cases
GlaxoSmithKline PLC on Thursday lost a bid for summary judgment in three antitrust cases pending in Pennsylvania that allege the company delayed sales of a generic version of Flonase by filing baseless petitions with the U.S. Food and Drug Administration.